UAB "Pharmasanta group" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
0 |
0 |
530,867 |
-530,867 |
-530,867 |
- |
-13.55 |
- |
- |
-1,078,268 |
14,607,224 |
13,423,930 |
48,970 |
2022 |
---|
111,026 |
23,522 |
368,844 |
-368,844 |
-78,145 |
-39.03 |
-8.86 |
22.38 |
-332.21 |
-1,447,111 |
12,820,340 |
11,022,262 |
350,531 |
2023 |
---|
75,150 |
19,025 |
1,440,679 |
1,440,679 |
364,729 |
-145.37 |
-1,751.30 |
14.23 |
1,917.07 |
-6,432 |
11,264,332 |
10,918,240 |
339,603 |
Register and
explore Okredo data2023 |
---|
75,150 |
19,025 |
1,440,679 |
1,440,679 |
364,729 |
-145.37 |
-1,751.30 |
14.23 |
1,917.07 |
-6,432 |
11,264,332 |
10,918,240 |
339,603 |
Register and
explore Okredo data2023
Turnover (€)
75,150 €-32 % *
Sales per employee (€)
19,025 €-19 % *
Profit before tax (€)
1,440,679 €291 % *
Net Profit (€)
1,440,679 €491 % *
Profit per employee (€)
364,729 €567 % *
Working capital requirement
-145.37 -272.46 % *
Debt-to-equity ratio
-1,751.30 -19,666.37 % *
Total profitability (%)
14.23 %-36.42 % *
Net profitability (%)
1,917.07 %677.07 % *
Equity (€)
-6,432 €100 % *
Amounts Payable And Liabilities (€)
11,264,332 €-12 % *
Non-current Assets (€)
10,918,240 €-1 % *
CurrentAssets (€)
339,603 €-3 % *